Skip to content

Clinical trials

Phase 2 Biliary Tract Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Phase: Phase 2 Country / region: Japan Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20134
20141
20152
20191
20211
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Kansai Hepatobiliary Oncology Group3
Bayer2
Boehringer Ingelheim1
EMD Serono Research & Development Institute, Inc.1
Eisai Co., Ltd.1
Eli Lilly and Company1
GlaxoSmithKline1
Novartis Pharmaceuticals1
Seagen, a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms15
Colorectal Neoplasms4
Breast Neoplasms3
Neoplasms3
Stomach Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Gallbladder Neoplasms2
Gastrointestinal Stromal Tumors2
Ovarian Neoplasms2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.